Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review

被引：6
|
作者：
Zhong Fang-Fang [1 ,2 ]
Yang You [1 ,2 ]
Liu Wen-Jun [1 ,2 ]
机构：
[1] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Pediat, Birth Defects Clin Med Res Ctr Sichuan Prov, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
来源：
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES | 2021年 / 21卷 / 02期
关键词：
Childhood leukemia; Notch1 signaling pathway; T-cell acute lymphocytic leukemia; T-ALL; ACUTE LYMPHOBLASTIC-LEUKEMIA; FBXW7; MUTATIONS; AGENT DEMCIZUMAB; PTEN; RESISTANCE; DROSOPHILA; APOPTOSIS; CHILDREN; RISK; ACTIVATION;
D O I：
10.17305/bjbms.2020.4687
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Childhood leukemia is cancer that seriously threatens the life of children in China. Poor sensitivity to chemotherapy and susceptibility to drug resistance are the reasons for the treatment of T-cell acute lymphocytic leukemia (T-ALL) being extremely difficult. Moreover, traditional intensive chemotherapy regimens cause great damage to children. Therefore, it is highly important to search for targeted drugs and develop a precise individualized treatment for child patients. There are activating mutations in the NOTCH1 gene in more than sous of human T-ALLs and the Notch signaling pathway is involved in the pathogenesis of T-ALL. In this review, we summarize the progress in research on T-ALL and Notch1 signaling pathway inhibitors to provide a theoretical basis for the clinical treatment of T-ALL.
引用
收藏
页码：136 / 144
页数：9
相关论文
共 50 条
  • [21] Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia
    Koyama, D.
    Kikuchi, J.
    Hiraoka, N.
    Wada, T.
    Kurosawa, H.
    Chiba, S.
    Furukawa, Y.
    LEUKEMIA, 2014, 28 (06) : 1216 - 1226
  • [22] A wide role for NOTCH1 signaling in acute leukemia
    Chiaramonte, R
    Basile, A
    Tassi, E
    Calzavara, E
    Cecchinato, V
    Rossi, V
    Biondi, A
    Comi, P
    CANCER LETTERS, 2005, 219 (01) : 113 - 120
  • [23] LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia
    Wang, Yaping
    Wu, Peng
    Lin, Rufeng
    Rong, Liucheng
    Xue, Yao
    Fang, Yongjun
    SCIENTIFIC REPORTS, 2015, 5
  • [24] Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphoma
    Sakamoto, Yuma
    Ishida, Takashi
    Masaki, Ayako
    Murase, Takayuki
    Ohtsuka, Eiichi
    Takeshita, Morishige
    Muto, Reiji
    Choi, Ilseung
    Iwasaki, Hiromi
    Ito, Asahi
    Kusumoto, Shigeru
    Nakano, Nobuaki
    Tokunaga, Masahito
    Yonekura, Kentaro
    Tashiro, Yukie
    Suehiro, Youko
    Iida, Shinsuke
    Utsunomiya, Atae
    Ueda, Ryuzo
    Inagaki, Hiroshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (02) : 206 - 221
  • [25] Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2-and γ-secretase inhibitors
    Silva, Ana
    Jotta, Patricia Y.
    Silveira, Andre B.
    Ribeiro, Daniel
    Brandalise, Silvia R.
    Yunes, J. Andres
    Barata, Joao T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (04): : 674 - 678
  • [26] NOTCH1 and FBXW7 Mutations Favor Better Outcome in Pediatric South Indian T-Cell Acute Lymphoblastic Leukemia
    Natarajan, Valliyammai
    Bandapalli, Obul R.
    Rajkumar, Thangarajan
    Sagar, Tenali Gnana
    Karunakaran, Nirmala
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (01) : E23 - E30
  • [27] Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia
    Xi, Mengping
    Guo, Shanshan
    Bayin, Caicike
    Peng, Lijun
    Chuffart, Florent
    Bourova-Flin, Ekaterina
    Rousseaux, Sophie
    Khochbin, Saadi
    Mi, Jian-Qing
    Wang, Jin
    FRONTIERS OF MEDICINE, 2022, 16 (03) : 442 - 458
  • [28] Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial
    Jenkinson, S.
    Koo, K.
    Mansour, M. R.
    Goulden, N.
    Vora, A.
    Mitchell, C.
    Wade, R.
    Richards, S.
    Hancock, J.
    Moorman, A. V.
    Linch, D. C.
    Gale, R. E.
    LEUKEMIA, 2013, 27 (01) : 41 - 47
  • [29] Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia
    Bertulfo, Kalay
    Perez-Duran, Pablo
    Miller, Hannah
    Ma, Cindy
    Ambesi-Impiombato, Alberto
    Samon, Jeremy
    Mackey, Adam
    Lin, Wen- Hsuan Wendy
    Ferrando, Adolfo A.
    Palomero, Teresa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 122 (14)
  • [30] Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model
    Masuda, Shigeo
    Kumano, Keiki
    Suzuki, Takahiro
    Tomita, Taisuke
    Iwatsubo, Takeshi
    Natsugari, Hideaki
    Tojo, Arinobu
    Shibutani, Makoto
    Mitsumori, Kunitoshi
    Hanazono, Yutaka
    Ogawa, Seishi
    Kurokawa, Mineo
    Chiba, Shigeru
    CANCER SCIENCE, 2009, 100 (12): : 2444 - 2450
12345